Cluster 1 included signatures associated with immune response, WNT and TGF beta signaling, epithelial‐mesenchymal transition, prostate cancer basal differentiation, and AR low/double negative prostate cancer subtypes. The gene discussed is AR; the disease is prostate cancer.